AstraZeneca has announced the opening of a new development operations centre in Bengaluru to support expansion of itsfootprint inIndia.

 

“The development operations centre will employ over 30clinical researchexperts that handle over 20 studies in 150 sites across India,” AstraZenecasaid in the press statement.

 

This expansion will focus on managing clinical studies inIndiato not only support the global clinical drug development, but also the local business with clinical data and evidence, it added.

 

“Because of the excellent skills of Indianclinical research experts and the improvement of regulations and approval timelines, we are pleased to expand our operations and continue to lead clinical research in India,” AstraZenecaDevelopment Operations (Site Management and Monitoring), Asia,Middle East&Africa(AMEA)Senior Regional DirectorMelissa Gradysaid.

 

The unit will support development of AstraZeneca's medicines, hostingclinical trialexperts focused on the company's core therapeutic areas - oncology, cardiovascular, renal and metabolism, as well as respiratory, the statement said.

 

Source: PTI

This expansion will focus on managing clinical studies in India to not only support the global clinical drug development, but also the local business with clinical data and evidence.